drugset / Trial / NCT03701061
Durability and Impact of the Seasonal Influenza Vaccine on H5 Induced B Cell Response
Phase 4
Completed
12 enrolled
Emory University
National Institute of Allergy and Infectious Diseases (NIAID) · collab
Non-randomizedParallel-groupOpen-labelBasic science
Summary
The study is a prospective single site exploratory study to examine the impact of Food and Drug Administration (FDA) approved seasonal flu vaccine on the immune responses of H5N1 vaccine previously received with or without the AS03 adjuvant.
Timeline
- Start
- 2018-10-11
- Primary completion
- 2019-02-28
- Completion
- 2020-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluarix Quadrivalent | Vaccine | — | — |